News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
635,908 Results
Type
Article (50096)
Company Profile (148)
Press Release (585663)
Multimedia
Podcasts (118)
Webinars (18)
Section
Business (180708)
Career Advice (1974)
Deals (29682)
Drug Delivery (114)
Drug Development (81606)
Employer Resources (122)
FDA (16893)
Job Trends (12872)
News (317336)
Policy (33202)
Tag
Academia (2472)
Academic (2)
Accelerated approval (12)
Adcomms (31)
Allergies (94)
Alliances (48057)
ALS (118)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (188)
Approvals (16860)
Artificial intelligence (342)
Autoimmune disease (34)
Automation (16)
Bankruptcy (262)
Best Places to Work (10000)
BIOSECURE Act (21)
Biosimilars (129)
Biotechnology (104)
Bladder cancer (98)
Brain cancer (39)
Breast cancer (367)
Cancer (2925)
Cardiovascular disease (229)
Career advice (1674)
Career pathing (29)
CAR-T (182)
CDC (26)
Cell therapy (507)
Cervical cancer (22)
Clinical research (67194)
Collaboration (1064)
Company closure (3)
Compensation (496)
Complete response letters (30)
COVID-19 (2537)
CRISPR (58)
C-suite (319)
Cystic fibrosis (116)
Data (3001)
Decentralized trials (2)
Denatured (38)
Depression (74)
Diabetes (362)
Diagnostics (5470)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (38)
Drug discovery (169)
Drug pricing (148)
Drug shortages (36)
Duchenne muscular dystrophy (130)
Earnings (72846)
Editorial (46)
Employer branding (16)
Employer resources (109)
Events (96234)
Executive appointments (822)
FDA (18595)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (898)
Gene editing (126)
Generative AI (31)
Gene therapy (386)
GLP-1 (883)
Government (4417)
Grass and pollen (4)
Guidances (172)
Healthcare (16171)
HIV (43)
Huntington's disease (28)
IgA nephropathy (42)
Immunology and inflammation (165)
Immuno-oncology (11)
Indications (39)
Infectious disease (2700)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (57)
Intellectual property (122)
Interviews (358)
IPO (13409)
IRA (56)
Job creations (3273)
Job search strategy (1417)
Kidney cancer (14)
Labor market (39)
Layoffs (501)
Leadership (22)
Legal (7618)
Liver cancer (80)
Longevity (9)
Lung cancer (413)
Lymphoma (212)
Machine learning (11)
Management (40)
Manufacturing (394)
MASH (95)
Medical device (10978)
Medtech (10984)
Mergers & acquisitions (16972)
Metabolic disorders (916)
Multiple sclerosis (103)
NASH (20)
Neurodegenerative disease (139)
Neuropsychiatric disorders (39)
Neuroscience (2226)
NextGen: Class of 2025 (5476)
Non-profit (3903)
Now hiring (27)
Obesity (472)
Opinion (279)
Ovarian cancer (94)
Pain (110)
Pancreatic cancer (116)
Parkinson's disease (192)
Partnered (18)
Patents (296)
Patient recruitment (163)
Peanut (47)
People (52378)
Pharmaceutical (38)
Pharmacy benefit managers (24)
Phase I (20514)
Phase II (29070)
Phase III (22578)
Pipeline (1640)
Policy (230)
Postmarket research (3133)
Preclinical (8853)
Press Release (67)
Prostate cancer (147)
Psychedelics (44)
Radiopharmaceuticals (256)
Rare diseases (484)
Real estate (4894)
Recruiting (47)
Regulatory (23790)
Reports (35)
Research institute (2276)
Resumes & cover letters (298)
Rett syndrome (10)
RNA editing (8)
RSV (43)
Schizophrenia (96)
Series A (160)
Series B (97)
Service/supplier (10)
Sickle cell disease (59)
Special edition (21)
Spinal muscular atrophy (161)
Sponsored (29)
Startups (3233)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (63)
The Weekly (78)
Vaccines (759)
Venture capital (46)
Weight loss (314)
Women's health (41)
Worklife (14)
Date
Today (70)
Last 7 days (347)
Last 30 days (1793)
Last 365 days (30076)
2025 (16609)
2024 (32887)
2023 (36576)
2022 (47125)
2021 (50262)
2020 (48075)
2019 (41003)
2018 (31067)
2017 (30363)
2016 (29510)
2015 (33906)
2014 (27838)
2013 (23896)
2012 (25069)
2011 (25505)
2010 (24302)
Location
Africa (829)
Alabama (66)
Alaska (6)
Arizona (166)
Arkansas (13)
Asia (42488)
Australia (6751)
California (6875)
Canada (2165)
China (705)
Colorado (290)
Connecticut (314)
Delaware (187)
Europe (88749)
Florida (1047)
Georgia (227)
Hawaii (1)
Idaho (41)
Illinois (601)
India (32)
Indiana (324)
Iowa (17)
Japan (236)
Kansas (102)
Kentucky (26)
Louisiana (13)
Maine (40)
Maryland (983)
Massachusetts (5211)
Michigan (215)
Minnesota (362)
Mississippi (2)
Missouri (81)
Montana (24)
Nebraska (22)
Nevada (72)
New Hampshire (51)
New Jersey (2036)
New Mexico (26)
New York (1984)
North Carolina (1045)
North Dakota (10)
Northern California (3002)
Ohio (211)
Oklahoma (16)
Oregon (30)
Pennsylvania (1435)
Puerto Rico (14)
Rhode Island (36)
South America (1099)
South Carolina (26)
South Dakota (1)
Southern California (2626)
Tennessee (114)
Texas (1052)
United States (25703)
Utah (191)
Virginia (185)
Washington D.C. (74)
Washington State (620)
West Virginia (3)
Wisconsin (73)
635,908 Results for "hunan tigermed xiangya drug r and d ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug
June 9, 2025
·
10 min read
Press Releases
Tigermed Reports Full Year 2024 Results
March 28, 2025
·
9 min read
Press Releases
Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)
July 8, 2025
·
8 min read
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
Are long R&D cycles, overwhelming literature reviews, or patent bottlenecks slowing your path to innovation? In the fast-evolving life science landscape, AI is no longer a luxury, it’s a necessity.
June 25, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
June 3, 2025
·
2 min read
Business
Tigermed Reports Full Year 2023 Results
Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.
March 28, 2024
·
9 min read
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
·
7 min read
·
BioSpace Insights
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Genetown
NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit
NeuroSense Therapeutics Ltd., a company developing novel treatments for severe neurodegenerative diseases, announces that Vice President of R&D, Dr. Shiran Zimri will be a key presenter at the ALS Drug Development Summit in Boston, Mass.
May 20, 2024
·
7 min read
1 of 63,591
Next
